Putnam Associates is a premier strategy consulting firm serving biopharmaceutical, diagnostics, and medical device clients, and the private equity / venture capital community. For 30 years, we have offered objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle.
Eric Auger, Partner, was a speaker at the American Society of Gene & Cell Therapy’s (ASGCT) annual meeting in Chicago held on May 17th. The symposium focused on whether current pricing strategies assure fair access to the values of gene-based therapies.read more
Putnam is honored to be a member of the MIT Solve community for a second year in a row! Yuanfei Wang, PhD will be Putnam’s delegate for the 3-day Annual Flagship Meeting kicking off today. The meeting featuresread more
June, Associate Consultant at Putnam, is one of 35 American students to be awarded this year’s competitive Gates Cambridge Scholarship. She will attend Cambridge University to earn a PhD inRead More
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.